Chinese team says its all-in-one mini artificial pancreas offers next-gen diabetes care

Unlike existing commercial systems for managing diabetes that typically require patients to wear two separate patches for monitoring and hormone delivery, the new prototype combines both functions in a single coin-sized device.

Researchers from the University of Electronic Science and Technology of China said their smartphone-controlled intelligent device offered a shift for next-generation diabetes management.

“We present a wearable closed-loop insulin micropump that enables a miniaturised artificial pancreas in diabetes therapy,” the researchers said in a paper published in the peer-reviewed journal Microsystems & Nanoengineering on September 29.